Myocardial Blood Volume Measurement by Real-Time Myocardial Perfusion Echocardiography Correlates to Myocardial Compressibility by Cardiac Magnetic Resonance Imaging in Healthy Subjects

Mayo Clinic1 site in 1 country115 target enrollmentFebruary 9, 2021

ConditionsHealthy Adults

Overview

Phase: N/A
Intervention: Not specified
Conditions: Healthy Adults
Sponsor: Mayo Clinic
Enrollment: 115
Locations: 1
Primary Endpoint: Myocardial blood volume
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study is being done to find out the normal amount of blood within the heart muscle and the variations in this blood flow between a cardiac MRI and TTE.

Registry

clinicaltrials.gov

Start Date

February 9, 2021

End Date

November 11, 2021

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Mayo Clinic

Responsible Party

Principal Investigator

Courtney E. Bennett

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

•Age ≥ 18 years.
•Available for testing performed in Rochester, MN.
•Willing to undergo both an echocardiogram with RTMPE and CMR.
•Study subject providing consent.

Exclusion Criteria

•Adults \< 18 years.
•BMI \<30 kg/m\^
•Hypertension.
•Diabetes Mellitus.
•Cardiomyopathy or structural heart disease.
•Known coronary artery disease or history of myocardial infarction.
•Contraindication to echo enhancement agent or gadolinium administration such as an allergy.
•Renal GFR \< 50 mL/mL.
•Females who are pregnant.
•Subject unwilling to consent.